PTC Therapeutics (PTCT) Misses Q3 EPS by 3c

PTC Therapeutics (NASDAQ: PTCT) reported Q3 EPS of ($0.93), $0.03 worse than the analyst estimate of ($0.90). Revenue for the quarter came in at $1.69 million versus the consensus estimate of $1.76 million.

For earnings history and earnings-related data on PTC Therapeutics (PTCT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Diana Shipping withdraws bid to acquire Genco Shipping